8/4/2014 9:18:55 AM
(Reuters) - Canada's Tekmira Pharmaceuticals Corp.,, whose shares have soared in the past fortnight on hopes for its Ebola therapy, said its drug was not used to treat two U.S. aid workers who were recently infected, a Canadian news agency reported.
Tekmira hopes to produce the first treatment for the deadly virus, which has killed more than 700 people in West Africa since February, and there had been speculation its therapy was given to American missionary Nancy Writebol and another aid worker, Dr. Kent Brantly.
Writebol and Brantly, who work for U.S.-based Christian relief groups SIM and Samaritan's Purse, were both infected in Liberia. Brantly is being treated at the Emory University Hospital in Atlanta.
Help employers find you! Check out all the jobs and post your resume.
comments powered by